The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Status Completed

Clinical Trial Summary

An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.

Clinical Trial Description

This will be an open label study conducted in healthy male participants at a single centre. Each participant will participate in a screening visit and 2 study periods. At the first study period, all participants will receive a single dose of BCT197 and at study period 2, all participants will receive 14 daily doses of itraconazole and a single dose of BCT197. ;

Study Design

Related Conditions & MeSH terms

Interaction

Clinical Trial Details

NCT number	NCT03498170
Study type	Interventional
Source	Mereo BioPharma
Contact
Status	Completed
Phase	Phase 1
Start date	March 19, 2018
Completion date	May 9, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02926326` - The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers	Phase 1
Completed	`NCT04257955` - COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer
Recruiting	`NCT04249674` - Impact of CYP2D6 Genetic Polymorphisms on the Vulnerability to Drug-drug Interactions With Tramadol
Completed	`NCT01482117` - The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers	N/A
Terminated	`NCT04842981` - Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis	Phase 1/Phase 2
Completed	`NCT01447472` - -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms	Phase 1
Active, not recruiting	`NCT05425303` - System Dynamics Model for Acute Non-contact Lower Extremity Injuries Prediction
Not yet recruiting	`NCT06053411` - Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac	Early Phase 1
Completed	`NCT02067936` - Walking the Isobole of Drug Interaction	N/A
Completed	`NCT05365451` - Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters	Early Phase 1